Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    I have it all …  and I’m quietly falling apart — The Barefoot Investor

    November 17, 2026

    A Bull Market for Pokémon Cards, Fueled by Pikachu and Nostalgia

    November 17, 2026

    John H. Powers III to Lead NIAID Amid Turmoil

    November 17, 2026
    Facebook X (Twitter) Instagram
    Trending
    • I have it all …  and I’m quietly falling apart — The Barefoot Investor
    • A Bull Market for Pokémon Cards, Fueled by Pikachu and Nostalgia
    • John H. Powers III to Lead NIAID Amid Turmoil
    • How High-Growth Brands Can Win the AI Search Race
    • Island is a new screen-time app that turns staying off your phone into a game
    • 32 Products Reviewers Won’t Vacation Without
    • Trump’s Plan for A.I. Supremacy Fuels Resistance in the Philippines
    • A Flurry of Thanksgiving Travel Deals for Vacation Shoppers
    Facebook X (Twitter)
    SBM Global News
    Demo
    • Home
    • Top Stories
      • Politics
    • Business
      • Small Business
      • Marketing
    • Finance
      • Investment
    • Technology

      Island is a new screen-time app that turns staying off your phone into a game

      November 17, 2026
      Read More

      Fan Fiction Site AO3 Returns, and So Do Its Readers, in Droves

      November 16, 2026
      Read More

      LiveFaceSwap AI – Company Profile

      November 15, 2026
      Read More

      Amazon’s new Kindle Colorsoft is a premium e-reader with a premium price

      November 14, 2026
      Read More

      Wall Street Braces for Anthropic’s Spending

      November 14, 2026
      Read More
    • Lifestyle
      • Travel
    • Feel Good
    • Get In Touch
    SBM Global News
    Demo
    Home»Health»John H. Powers III to Lead NIAID Amid Turmoil
    Health

    John H. Powers III to Lead NIAID Amid Turmoil

    By Staff WriterNovember 17, 20265 Mins Read
    Facebook Twitter LinkedIn Reddit Email
    #image_title
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Dr. John H. Powers III, an infectious disease researcher, was appointed on Monday to lead the National Institutes of Health division on infectious diseases, giving him control of a politically contentious institute with a budget of over $6.5 billion and responsibility for research into such pressing threats as measles and Ebola.

    His designation as director of the National Institute of Allergy and Infectious Diseases, a position held for nearly four decades by Dr. Anthony S. Fauci, caps a rapid rise for Dr. Powers, who until recently was an N.I.H. contractor and clinical trials design specialist.

    Since the start of the second Trump administration, Dr. Powers gained influence among senior health officials as he was tapped to study vaccine injuries, a priority of Health Secretary Robert F. Kennedy Jr.

    Early last year, Dr. Powers worked with Dr. Matthew Memoli, the No. 2 official at the N.I.H. and a critic of Covid vaccine mandates, to obtain sets of data related to vaccines and autism from the Centers for Disease Control and Prevention, according to emails reviewed by The New York Times.

    The emails said that Dr. Powers and possibly other N.I.H. contractors would be analyzing the C.D.C. data, and that autism scientists at the N.I.H. had been unaware of N.I.H. leaders’ requests for the data. (Past large studies have found no link between vaccines and autism.)

    After he was put in charge of the infectious diseases institute on a temporary basis around the middle of this year, Dr. Powers helped develop a major research study on health problems following vaccination or infection.

    He appeared beside Mr. Kennedy at an N.I.H. event announcing the initiative, counting down before the health secretary cut the ribbon for cameras.

    At a briefing on Monday, Dr. Powers said that he had never studied the link between vaccines and autism and that the question of whether vaccines caused autism was a “policy question” that was beyond his remit as director of the infectious diseases institute.

    The N.I.H. said that Dr. Powers did not ultimately perform any work on the C.D.C. vaccine data.

    “The real question here now is, ‘Can we have the evidence to actually show where and in what populations a vaccine is beneficial for people?’” Dr. Powers said. “And benefits are actually what justify any potential harms.”

    An expert on the design of clinical trials, Dr. Powers made his name developing a widely used measure of the severity of flu symptoms.

    Dr. Powers has also worked at Leidos Biomedical Research, a company that supports government research efforts; held an academic appointment at the George Washington University School of Medicine; and treated patients as an infectious diseases specialist.

    His sensitivity to the rare but serious side effects of vaccines has endeared him to supporters. Some colleagues said that Dr. Powers has sought to ensure that N.I.H. studies of vaccine harms hewed to scientific goals, and not a political agenda.

    Brianne Dressen, who was diagnosed with post-vaccine neuropathy after participating in a clinical trial in 2020 of AstraZeneca’s Covid vaccine, which was never widely administered in the United States, said she met Dr. Powers this summer as they worked together on the N.I.H.’s vaccine injury study.

    Demo

    “He understands that these aren’t just study participants,” Ms. Dressen, a patient adviser on the N.I.H. study, said in an interview. “He understands these are real patients, and especially dealing with people with severe chronic conditions, these are very vulnerable patients.”

    Diana Zuckerman, a scientist and the president of the nonprofit National Center for Health Research, who has worked with Dr. Powers, described him as “a moderate on these issues.”

    “He’s absolutely committed to ensuring that as many people can safely get vaccines as possible,” she said. “Like many of us,” she added, Dr. Powers “recognized that some people are harmed by vaccines, and the numbers are proportionally small, but the harm can be great.”

    Since President Trump returned to office last year, the country’s infectious diseases research apparatus has been thrown into chaos, generating alarm among Democrats in Congress amid outbreaks of hantavirus and Ebola.

    Dr. John H. Powers IIICredit…National Institute of Allergy and Infectious Diseases

    Dr. Fauci’s successor, Dr. Jeanne Marrazzo, a scientist renowned for research on sexually transmitted infections, was fired by Mr. Kennedy last year after she filed a whistle-blower complaint against the Trump administration. (She has since sued the administration; a federal judge this month denied a government bid to have the lawsuit dismissed.)

    Then Dr. Jeffery Taubenberger, who had led a major effort to sequence the 1918 Spanish flu virus and who stepped in as acting director of the infectious diseases institute last year, was pushed aside, creating weeks of uncertainty this year about who was running the institute.

    Federal investigators have also demanded phone, email, grant and payment records related to a number of infectious disease scientists, including Dr. Fauci, as part of a sprawling set of inquiries related to the origins of the Covid pandemic.

    And several large research networks that test vaccines and treatments for H.I.V., tuberculosis and emerging infectious diseases remain in limbo after delays from the Trump administration in starting the process to renew their funding.

    During Dr. Powers’s tenure as acting director of the infectious diseases institute, the second-largest arm of the N.I.H., officials said that he has defended the agency’s portfolio. But the Trump administration has exercised an unusual level of control over medical research funding decisions.

    And some scientists worried that Dr. Powers did not have the same breadth of infectious disease research experience as his predecessors, putting him at a disadvantage as he fills the leadership vacuum at the country’s premier infectious disease institute.

    In January, Dr. Powers appeared on a panel about the future of the infectious diseases institute organized by the MAHA Institute, which is led by Tony Lyons, a longtime friend and business associate of Mr. Kennedy’s.

    Apoorva Mandavilli and Carolyn Y. Johnson contributed reporting.

    View original article here

    Share. Facebook Twitter LinkedIn Email Reddit
    Previous ArticleHow High-Growth Brands Can Win the AI Search Race
    Next Article A Bull Market for Pokémon Cards, Fueled by Pikachu and Nostalgia

    Related Posts

    What Gastroenterologists Wish Everyone Knew About Their Poop Schedule

    November 16, 2026
    Read More

    The U.S. Lost Its Measles Elimination Status — Here’s What That Means For Public Health

    November 15, 2026
    Read More

    Why a Little Extra Weight May Benefit Older People

    November 14, 2026
    Read More
    Add A Comment

    Leave A Reply Cancel Reply

    Demo
    Top Posts

    Former FBI, CIA Head Has ‘Serious Concerns’ With Trump Cabinet Picks

    December 28, 2024435

    Emirates to operate next-gen A350 on the third daily service to Cape Town

    January 14, 2026256

    AAVE Price Prediction: Target $215-225 by Mid-January 2025 as Technical Indicators Signal Bullish Momentum

    December 15, 2025240

    Wall Street Slumps As Alphabet, Qualcomm And Other Tech Stocks Fall

    February 7, 2026212
    Don't Miss
    Investment

    I have it all …  and I’m quietly falling apart — The Barefoot Investor

    By Staff WriterNovember 17, 20263 Mins Read

    “Don’t you dare!” I thundered at my five-year-old.He was standing in his room sobbing, about…

    Read More

    A Bull Market for Pokémon Cards, Fueled by Pikachu and Nostalgia

    November 17, 2026

    John H. Powers III to Lead NIAID Amid Turmoil

    November 17, 2026

    How High-Growth Brands Can Win the AI Search Race

    November 17, 2026
    Stay In Touch
    • Facebook
    • Twitter
    Demo
    Find More
    Trending News
    • I have it all …  and I’m quietly falling apart — The Barefoot Investor
    • A Bull Market for Pokémon Cards, Fueled by Pikachu and Nostalgia
    • John H. Powers III to Lead NIAID Amid Turmoil
    • How High-Growth Brands Can Win the AI Search Race
    • Island is a new screen-time app that turns staying off your phone into a game
    • 32 Products Reviewers Won’t Vacation Without
    • Trump’s Plan for A.I. Supremacy Fuels Resistance in the Philippines
    • A Flurry of Thanksgiving Travel Deals for Vacation Shoppers
    • Nvidia: Now What? – A Wealth of Common Sense
    • Megaspeed Says Alice Huang Left Company in August 2025
    Other News
    • Business
    • Feel Good
    • Finance
    • Fitness
    • Health
    • Investment
    • Lifestyle
    • Marketing
    • Politics
    • Small Business
    • Technology
    • Top Stories
    • Travel
    About Us

    Small Business Minder brings together business and related news from around the world in one place. Follow us for all the business news you'll need.

    Facebook X (Twitter)
    Our Picks

    I have it all …  and I’m quietly falling apart — The Barefoot Investor

    November 17, 2026

    A Bull Market for Pokémon Cards, Fueled by Pikachu and Nostalgia

    November 17, 2026
    Most Popular

    Former FBI, CIA Head Has ‘Serious Concerns’ With Trump Cabinet Picks

    December 28, 2024435

    Emirates to operate next-gen A350 on the third daily service to Cape Town

    January 14, 2026256
    Categories
    © 2026 Small Business Minder
    • Home
    • Get In Touch

    Type above and press Enter to search. Press Esc to cancel.

    Ad Blocker Enabled!
    Ad Blocker Enabled!
    Our website is made possible by displaying online advertisements to our visitors. To get the most from our site, please disable your Ad Blocker.